Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Human medicine
Name of medicinal product: AZOPT
Active substances:
Estonian, English, Latin
ATC code: S01EC04
Dosage form: eye drops, suspension
Strength: 10mg 1ml
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Indication: AZOPT is indicated to decrease elevated intraocular pressure in: -ocular hypertension -open-angle glaucoma as monotherapy in adult patients unresponsive to beta-blockers or in adult patients in whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers or prostaglandin analogues.
Safety features: Yes
Marketing authorization holder: Novartis Europharm Limited 
Marketing authorization number: EU/1/00/129 
Marketing authorization issued on: March 10, 2000 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Assessment report:   
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported PƤritolumaa Additional information
1042782  AZOPT  eye drops, suspension  10mg 1ml 5ml 1TK  Prescription  100% 50%  6,75  06.02.2024     
1213074  AZOPT  eye drops, suspension  10mg 1ml 10ml 1TK  Prescription           
1213085  AZOPT  eye drops, suspension  10mg 1ml 5ml 3TK  Prescription           
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere